Vis enkel innførsel

dc.contributor.authorSmåvik Dasa, Marcus
dc.contributor.authorKristoffersen, Morten
dc.contributor.authorErsvær, Elisabeth
dc.contributor.authorBovim, Lars Peder Vatshelle
dc.contributor.authorBjørkhaug, Lise
dc.contributor.authorMoe-Nilssen, Rolf
dc.contributor.authorSagen, Jørn Vegard
dc.contributor.authorHaukenes, Inger
dc.date.accessioned2021-08-25T07:27:37Z
dc.date.available2021-08-25T07:27:37Z
dc.date.created2021-07-08T11:01:53Z
dc.date.issued2021
dc.identifier.issn1664-042X
dc.identifier.urihttps://hdl.handle.net/11250/2771074
dc.description.abstractPurpose: The female menstrual cycle (MC) is characterized by hormonal fluctuations throughout its different phases. However, research regarding its effect on athletic performance in high level athletes is sparse. The aim of this study was to (i) investigate the female MCs effect on strength and power performance in highly trained female team athletes throughout the MC and (ii) examine whether eumenorrheic participants with natural hormonal fluctuations displayed enhanced performance in the follicular phase (FP) versus the luteal phase (LP), compared to controls using hormonal contraceptives. Materials and Methods: A total of 29 athletes (Age 21.2 ± 3.3 years; weight 65.6 ± 8.7 kg; height 170.2 ± 8.0 cm; and fat free mass 52.7 ± 7.1) completed the study after a 6-week testing period (8 eumenorrheic participants and 21 hormonal contraceptive controls). Participants were recruited from the team sports soccer, handball and volleyball. Testing protocol consisted of maximal voluntary isometric grip strength, 20-m sprint, countermovement jump and pneumatic leg-press. Based on self-reported use of hormonal contraceptives, participants were divided into non-hormonal contraceptive group and hormonal contraceptive group, the latter working as a control group. Differences in performance between the FP and LP were investigated. MC phase was confirmed by serum hormonal levels through venous blood samples in the non-hormonal contraceptive group. Results: There were no statistically significant changes for the two different phases of the MC, in terms of physical performance for the whole group. Further, there was no significant difference between groups during the MC for any of the outcome variables, maximal voluntary isometric grip strength F(3.29) = 0.362; 20-m sprint F(3.24) = 0.710; countermovement jump F(3.26) = 2.361; and leg-press F(3.26) = 1.746. Conclusion: In high level female team athletes, no difference in performance was observed based on hormonal contraceptive status. This suggests that the MC does not alter acute strength and power performance on a group level in high level team athletes.en_US
dc.language.isoengen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleThe Female Menstrual Cycles Effect on Strength and Power Parameters in High-Level Female Team Athletesen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.rights.holder© 2021 Dasa, Kristoffersen, Ersvær, Bovim, Bjørkhaug, Moe-Nilssen, Sagen and Haukenes.
dc.description.versionpublishedVersionen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.3389/fphys.2021.600668
dc.identifier.cristin1920954
dc.source.journalFrontiers in Physiologyen_US
dc.source.volume12en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal